Proteomics- and BRET- screens identify SPRY2 as a Ras effector that impacts its membrane organization. [PDF]
Pavic K +8 more
europepmc +1 more source
Class A and B GPCRs trigger rapid Gα<sub>s</sub> translocation to late and slow recycling endosomes. [PDF]
Laniel A +5 more
europepmc +1 more source
Negative Allosteric Modulation of Agonist-Induced M<sub>2</sub> Muscarinic Receptor/β-Arrestin Interaction by Serum Autoantibodies from Patients with Chronic Chagas Disease. [PDF]
Carrera Páez LC +7 more
europepmc +1 more source
Development of a Genetically Encoded and Potent PDE6D Inhibitor. [PDF]
Gómez-Mulas A +7 more
europepmc +1 more source
Novel <i>GNAO1</i> variant in α-helical domain reveals alternative mechanism of disease. [PDF]
Ludlam WG +4 more
europepmc +1 more source
A high-throughput screening approach to discover potential colorectal cancer chemotherapeutics: repurposing drugs to identify novel disruptors of 14-3-3 proteins. [PDF]
He S +7 more
europepmc +1 more source
LAP2α drives breast tumorigenesis by mitigating replication stress. [PDF]
Ma Y +10 more
europepmc +1 more source
Synthetic Multidomain Proteins Containing Unstructured and α‑Helical Linkers Reveal a Differential Impact of Molecular Crowding on Catalytic Activity and Conformation. [PDF]
Sultana A +3 more
europepmc +1 more source
Influence of PARP1 on CRISPR/Cas9 induced double strand break repair in proliferating cells. [PDF]
Wimmer T +5 more
europepmc +1 more source
The pathway-independent positive allosteric modulator C1 allows for the identification of active Y<sub>4</sub> receptor relevant positions. [PDF]
Schüß C +8 more
europepmc +1 more source

